Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 491 word(s) 491 2020-12-15 07:26:14

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Xu, C. Hartnup Disease. Encyclopedia. Available online: (accessed on 15 April 2024).
Xu C. Hartnup Disease. Encyclopedia. Available at: Accessed April 15, 2024.
Xu, Camila. "Hartnup Disease" Encyclopedia, (accessed April 15, 2024).
Xu, C. (2020, December 23). Hartnup Disease. In Encyclopedia.
Xu, Camila. "Hartnup Disease." Encyclopedia. Web. 23 December, 2020.
Hartnup Disease

Hartnup disease is a condition caused by the body's inability to absorb certain protein building blocks (amino acids) from the diet.

genetic conditions

1. Introduction

Hartnup disease affected individuals are not able to use these amino acids to produce other substances, such as vitamins and proteins. Most people with Hartnup disease are able to get the vitamins and other substances they need with a well-balanced diet.

People with Hartnup disease have high levels of various amino acids in their urine (aminoaciduria). For most affected individuals, this is the only sign of the condition. However, some people with Hartnup disease have episodes during which they exhibit other signs, which can include skin rashes; difficulty coordinating movements (cerebellar ataxia); and psychiatric symptoms, such as depression or psychosis. These episodes are typically temporary and are often triggered by illness, stress, nutrient-poor diet, or fever. These features tend to go away once the trigger is remedied, although the aminoaciduria remains. In affected individuals, signs and symptoms most commonly occur in childhood.

2. Frequency

Hartnup disease is estimated to affect 1 in 30,000 individuals.

3. Causes

Hartnup disease is caused by mutations in the SLC6A19 gene. This gene provides instructions for making a protein called B0AT1, which is primarily found embedded in the membrane of intestine and kidney cells. The function of this protein is to transport certain amino acids into cells. In the intestines, amino acids from food are transported into intestinal cells then released into the bloodstream so the body can use them. In the kidneys, amino acids are reabsorbed into the bloodstream instead of being removed from the body in urine. In the body, these amino acids are used in the production of many other substances, including vitamins and proteins. One particular amino acid transported by B0AT1, tryptophan, is needed to produce vitamin B3 (also known as niacin).

SLC6A19 gene mutations result in the production of a B0AT1 protein with reduced activity. As a result, specific amino acids cannot be taken in by cells and are instead removed from the body as waste. Because these amino acids are removed from the body without being used, people with this condition may be lacking (deficient) in certain amino acids and vitamins. However, individuals who are nutrient-deficient due to their diet, illness, stress, or a variety of other reasons, can develop serious signs and symptoms of this condition including rashes, cerebellar ataxia, and psychiatric symptoms. Researchers believe that many of these features are related to a deficiency of tryptophan and niacin, specifically.

4. Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

5. Other Names for This Condition

  • Hartnup disorder

  • Hartnup's disease

  • neutral amino acid transport defect


  1. Azmanov DN, Kowalczuk S, Rodgers H, Auray-Blais C, Giguère R, Rasko JE, Bröer S, Cavanaugh JA. Further evidence for allelic heterogeneity in Hartnup disorder. Hum Mutat. 2008 Oct;29(10):1217-21. doi: 10.1002/humu.20777.
  2. Azmanov DN, Rodgers H, Auray-Blais C, Giguère R, Bailey C, Bröer S, Rasko JE, Cavanaugh JA. Persistence of the common Hartnup disease D173N allele inpopulations of European origin. Ann Hum Genet. 2007 Nov;71(Pt 6):755-61.
  3. Bröer S. The role of the neutral amino acid transporter B0AT1 (SLC6A19) inHartnup disorder and protein nutrition. IUBMB Life. 2009 Jun;61(6):591-9. doi:10.1002/iub.210. Review.
  4. Camargo SM, Singer D, Makrides V, Huggel K, Pos KM, Wagner CA, Kuba K,Danilczyk U, Skovby F, Kleta R, Penninger JM, Verrey F. Tissue-specific aminoacid transporter partners ACE2 and collectrin differentially interact withhartnup mutations. Gastroenterology. 2009 Mar;136(3):872-82. doi:10.1053/j.gastro.2008.10.055.
  5. Kleta R, Romeo E, Ristic Z, Ohura T, Stuart C, Arcos-Burgos M, Dave MH, WagnerCA, Camargo SR, Inoue S, Matsuura N, Helip-Wooley A, Bockenhauer D, Warth R,Bernardini I, Visser G, Eggermann T, Lee P, Chairoungdua A, Jutabha P, Babu E,Nilwarangkoon S, Anzai N, Kanai Y, Verrey F, Gahl WA, Koizumi A. Mutations inSLC6A19, encoding B0AT1, cause Hartnup disorder. Nat Genet. 2004Sep;36(9):999-1002.
  6. Seow HF, Bröer S, Bröer A, Bailey CG, Potter SJ, Cavanaugh JA, Rasko JE.Hartnup disorder is caused by mutations in the gene encoding the neutral aminoacid transporter SLC6A19. Nat Genet. 2004 Sep;36(9):1003-7.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 419
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 23 Dec 2020